Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02458430 · ClinicalTrials.gov registry record
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 120
- Enrollment target
NCT02458430 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 120 participants.
The verdict
NCT02458430 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Balance and gait problems cause severe impairments for people with Parkinson's disease In some Parkinson's disease patients the investigators see a loss of acetylcholine in the brain. In previous studies the investigators have shown that this loss of acetylcholine is related to impaired balance and gait function in Parkinson's disease. In this study the investigators will take a closer look at this finding.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-01-05 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02458430
The ClinicalTrials.gov registry entry for NCT02458430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02458430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02458430 about?
NCT02458430 is a clinical study titled "Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease". Balance and gait problems cause severe impairments for people with Parkinson's disease In some Parkinson's disease patients the investigators see a loss of acetylcholine in the brain. In previous studies the investigators have shown that this loss of acetylcholine is related to impaired balance and ...
What is the current status of trial NCT02458430?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2015-01-05. Estimated completion is 2020-12.
Who is sponsoring clinical trial NCT02458430?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.